K Number
K063709
Device Name
TS-BONE HIP TOOL
Date Cleared
2007-01-04

(21 days)

Product Code
Regulation Number
888.3030
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The TS-Bone Hip Tool™ is intended to stabilize a bone graft within the femoral head and neck to assist healing of an intraosseous fracture.
Device Description
Not Found
More Information

No
The provided 510(k) summary contains no mention of AI, ML, image processing, or any other technology typically associated with AI/ML in medical devices. The device description is not available, but the intended use and predicate device suggest a mechanical implant for bone stabilization.

No
The device is described as a tool intended to stabilize a bone graft, not to provide therapy itself. Its function is to assist in healing rather than to be a primary therapeutic agent.

No.
The device description states its intended use is to "stabilize a bone graft within the femoral head and neck to assist healing of an intraosseous fracture," which describes a therapeutic or surgical function, not a diagnostic one.

No

The 510(k) summary describes a "Hip Tool™" intended to stabilize a bone graft, and the predicate device is listed as "Hip Tool™ Implant". This strongly suggests a physical implantable device, not software. The lack of any mention of software, algorithms, or digital processing further supports this conclusion.

Based on the provided information, the TS-Bone Hip Tool™ is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is to "stabilize a bone graft within the femoral head and neck to assist healing of an intraosseous fracture." This describes a surgical tool used directly on the patient's body for a therapeutic purpose (stabilization and healing).
  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body (like blood, urine, or tissue) to provide information about a person's health. The TS-Bone Hip Tool™ does not involve testing samples outside the body.
  • Anatomical Site: The device is used on the "femoral head and neck," which is an anatomical site within the body, not a sample taken from the body.

Therefore, the TS-Bone Hip Tool™ is a surgical device, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

The TS-Bone Hip Tool™ is intended to stabilize a bone graft within the femoral head and neck to assist healing of an intraosseous fracture.

Product codes

HRS

Device Description

Not Found

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

femoral head and neck

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K022139

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 888.3030 Single/multiple component metallic bone fixation appliances and accessories.

(a)
Identification. Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.

0

K063709

510(k) SUMMARY

ADMINISTRATIVE INFORMATION

JAN - 4 2007

| Manufacturer Name: | Orthopedic Sciences, Inc.
3020 Old Ranch Parkway, Suite 325
Los Angeles, CA 90045 |
|--------------------|-----------------------------------------------------------------------------------------|
| Official Contact: | James K. Brannon. M.D. President/CEO |

Telephone (562) 799-5550 Fax (562) 799-5533

DEVICE NAME

Classification Name:Plate, fixation, bone
Trade/Proprietary Name:TS-Bone Hip ToolTM
Common Name:Bone plate

PREDICATE DEVICE INFORMATION

The predicate device for this modification is the Hip Tool™ Implant, a component of the Hip Tool™ Bone Graft Stabilization System, cleared by FDA on September 23, 2002 under K022139.

INTENDED USE

The TS-Bone Hip Tool™ is intended to stabilize a bone graft within the femoral head and neck to assist healing of an intraosseous fracture.

1

DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service

Image /page/1/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle-like symbol, with its wings forming a flowing, abstract shape. Encircling the symbol are the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement. The text is in all caps and appears to be in a simple, sans-serif font.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Orthopedic Sciences, Inc. % James K. Brannon, M.D. President/CEO 3020 Old Ranch Parkway, Suite 325 Los Angeles, California 90045

JAN 0 4 2007

Rc: K063709 Trade/Device Name: TS- Bone Hip ToolTM Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: Class II Product Code: HRS Dated: December 3, 2006 Received: December 14, 2006

Dear Dr. Brannon:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

2

Page 2 - James K. Brannon, M.D.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-frec number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Mark N. Melkerson

Mark N. N Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

Indications for Use

510(k) Number:

Device Name: TS-Bone Hip Tool™

Indications For Use:

The TS-Bone Hip Tool™ is intended to stabilize a bone graft within the femoral head and neck to assist healing of an intraosseous fracture.

Prescription Use × (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Oivisio Device Evaluation (ODE)
Division of General, Restorative,
and Neurological Devices
Page 1 of1_
Mer 12663705